Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BCRXBIOCRYST PHARMACEUTICALS INC

Nasdaq · CIK 0000882796
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts430

Identity from submissions API

NameBIOCRYST PHARMACEUTICALS INC
CIK0000882796
TickersBCRX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN621413174
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone919-859-1302
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
4505 EMPEROR BOULEVARD
SUITE 200
DURHAM
NC
27703
NC
Mailing address
4505 EMPEROR BOULEVARD
SUITE 200
DURHAM
NC
27703
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1968 filing rows loaded from submissions recent; extra archives: CIK0000882796-submissions-001.json (968 filings, 1995-02-14 to 2016-03-12).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000275 005-44055 261562589 34 12915
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000622 005-44055 261537825 34 8100
2026-11-04 10-Q 10-Q 0001628280-26-070112 000-23186 261522007 34 10170381 1 1
2026-11-04 8-K FORM 8-K 2.02,7.01,9.01 0001171843-26-007097 000-23186 261519995 34 451335 1 1
2026-09-02 4 PRIMARY DOCUMENT 0000882796-26-000065 6093
2026-09-02 4 PRIMARY DOCUMENT 0000882796-26-000063 4670
2026-09-02 4 PRIMARY DOCUMENT 0000882796-26-000061 4629
2026-09-02 4 PRIMARY DOCUMENT 0000882796-26-000059 4613
2026-09-02 4 PRIMARY DOCUMENT 0000882796-26-000057 4609
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000919 005-44055 261282925 34 14657
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000420 005-44055 261251593 34 8125
2026-08-05 S-8 FORM S-8 0001171843-26-005245 333-298006 261243897 33 203873 1 1
2026-08-05 10-Q 10-Q 0001628280-26-053300 000-23186 261243323 34 9649360 1 1
2026-08-05 8-K FORM 8-K 2.02,7.01,9.01 0001171843-26-005223 000-23186 261241276 34 387483 1 1
2026-08-04 8-K/A FORM 8-K/A 2.05 0001171843-26-005168 000-23186 261235393 34 192417 1 1
2026-06-29 8-K FORM 8-K 2.05,7.01,9.01 0001171843-26-004333 000-23186 261131290 34 240673 1 1
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000055 7113
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000053 8057
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000052 7070
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000045 7052
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000043 7078
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000041 7074
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000039 8538
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000037 7058
2026-06-15 4 PRIMARY DOCUMENT 0000882796-26-000035 7073
2026-06-12 8-K FORM 8-K 5.02,5.07,9.01 0001171843-26-004096 000-23186 261086737 34 372967 1 1
2026-06-02 4 PRIMARY DOCUMENT 0000882796-26-000033 4670
2026-06-02 4 PRIMARY DOCUMENT 0000882796-26-000031 6093
2026-06-02 4 PRIMARY DOCUMENT 0000882796-26-000029 4613
2026-06-02 4 PRIMARY DOCUMENT 0000882796-26-000027 4628
2026-06-02 4 PRIMARY DOCUMENT 0000882796-26-000025 4609
2026-05-19 4 PRIMARY DOCUMENT 0000882796-26-000023 4846
2026-05-18 144 xsl144X01/primary_doc.xml 0001628280-26-036012 000-23186 26994328 33 5187
2026-05-15 4 PRIMARY DOCUMENT 0000882796-26-000021 8649
2026-05-13 144 xsl144X01/primary_doc.xml 0001959173-26-003553 000-23186 26972286 33 5052
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000211 005-44055 26966348 34 8128
2026-05-06 10-Q 10-Q 0001628280-26-031238 000-23186 26948324 34 8765411 1 1
2026-05-06 8-K FORM 8-K 2.02,7.01,9.01 0001171843-26-003052 000-23186 26945785 34 323987 1 1
2026-05-04 8-K FORM 8-K 7.01,9.01 0001171843-26-002960 000-23186 26934590 34 227285 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000218 005-44055 26917679 34 7439
2026-04-23 ARS ARS 0001140361-26-016385 000-23186 26888920 34 3305088
2026-04-23 DEFA14A DEFA14A 0001140361-26-016373 000-23186 26888752 34 263359
2026-04-23 DEF 14A DEF 14A 0001628280-26-026822 000-23186 26888488 34 3647089 1 1
2026-04-07 4 PRIMARY DOCUMENT 0000882796-26-000019 7246
2026-04-07 3 xslF345X06/ownership.xml 0001171843-26-002301 11915
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000742 005-44055 26798249 34 7199
2026-03-24 4 PRIMARY DOCUMENT 0000882796-26-000017 8402
2026-03-20 144 xsl144X01/primary_doc.xml 0001959173-26-002529 000-23186 26777073 33 4339
2026-03-18 4 PRIMARY DOCUMENT 0000882796-26-000015 9017
2026-03-16 144 xsl144X01/primary_doc.xml 0001959173-26-002383 000-23186 26756935 33 5059
2026-03-03 4 PRIMARY DOCUMENT 0000882796-26-000013 4539
2026-03-03 4 PRIMARY DOCUMENT 0000882796-26-000011 12013
2026-03-03 4 PRIMARY DOCUMENT 0000882796-26-000009 4592
2026-03-03 4 PRIMARY DOCUMENT 0000882796-26-000007 4471
2026-03-03 4 PRIMARY DOCUMENT 0000882796-26-000005 4475
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001679 000-23186 26706951 33 4448
2026-02-26 10-K 10-K 0001628280-26-012240 000-23186 26687703 34 15253619 1 1
2026-02-26 8-K FORM 8-K 2.02,7.01,9.01 0001171843-26-001119 000-23186 26681698 34 435482 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-26-000127 005-44055 26625380 34 16760
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000024 005-44055 26609492 34 8021
2026-01-27 4 PRIMARY DOCUMENT 0000882796-26-000003 9390
2026-01-27 3 xslF345X02/ownership.xml 0001171843-26-000446 11507
2026-01-23 8-K/A FORM 8-K/A 5.02 0001171843-26-000405 000-23186 26556934 34 189428 1 1
2026-01-23 8-K 8-K 1.01,2.01,2.03,7.01,9.01 0001140361-26-002200 000-23186 26556882 34 2120896 1 1
2026-01-12 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001171843-26-000213 000-23186 26527038 34 246123 1 1
2026-01-09 3 xslF345X02/ownership.xml 0001171843-26-000173 20584
2026-01-09 8-K FORM 8-K 7.01 0001171843-26-000154 000-23186 26521336 34 185404 1 1
2025-12-23 4 PRIMARY DOCUMENT 0000882796-25-000045 6169
2025-12-23 4 PRIMARY DOCUMENT 0000882796-25-000043 6409
2025-12-23 4 PRIMARY DOCUMENT 0000882796-25-000041 15484
2025-12-22 144 xsl144X01/primary_doc.xml 0001959173-25-007875 000-23186 251591469 33 6940
2025-12-19 4 xslF345X05/ownership.xml 0001171843-25-008039 16302
2025-12-19 4 xslF345X05/ownership.xml 0001171843-25-008038 15318
2025-12-19 4 xslF345X05/ownership.xml 0001171843-25-008037 15298
2025-12-19 4 PRIMARY DOCUMENT 0000882796-25-000038 6910
2025-12-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003840 333-291678 251584859 33 1785
2025-12-18 424B3 424B3 0001140361-25-046040 333-291678 251583659 33 3747929
2025-12-16 4 PRIMARY DOCUMENT 0000882796-25-000036 4653
2025-12-16 4 PRIMARY DOCUMENT 0000882796-25-000033 6408
2025-12-16 4 PRIMARY DOCUMENT 0000882796-25-000031 6169
2025-12-16 CORRESP filename1.htm 0001140361-25-045599 417959
2025-12-15 144 xsl144X01/primary_doc.xml 0001959173-25-007729 000-23186 251570370 33 6313
2025-12-15 S-4/A S-4/A 0001140361-25-045461 333-291678 251570075 33 4641090
2025-12-12 8-K FORM 8-K 8.01,9.01 0001171843-25-007909 000-23186 251566586 34 260585 1 1
2025-12-11 8-K FORM 8-K 5.02 0001171843-25-007878 000-23186 251563515 34 186401 1 1
2025-12-03 4 PRIMARY DOCUMENT 0000882796-25-000027 12283
2025-12-03 144 xsl144X01/primary_doc.xml 0001959173-25-007471 000-23186 251546028 33 9445
2025-12-03 425 425 0001140361-25-044111 528505
2025-12-03 8-K 8-K 8.01,9.01 0001140361-25-044110 000-23186 251545029 34 668539 1 1
2025-12-02 4 PRIMARY DOCUMENT 0000882796-25-000023 4476
2025-12-02 4 PRIMARY DOCUMENT 0000882796-25-000021 4472
2025-12-02 4 PRIMARY DOCUMENT 0000882796-25-000019 4491
2025-12-02 144 xsl144X01/primary_doc.xml 0001959173-25-007427 000-23186 251542624 33 10198
2025-12-01 144 xsl144X01/primary_doc.xml 0001959173-25-007391 000-23186 251538633 33 4429
2025-11-25 144 xsl144X01/primary_doc.xml 0001628280-25-054000 000-23186 251521782 33 5880
2025-11-21 144 xsl144X01/primary_doc.xml 0001628280-25-053613 000-23186 251508401 33 5352
2025-11-20 S-4 S-4 0001140361-25-042879 333-291678 251503940 33 4027279 1 1
2025-11-17 4 PRIMARY DOCUMENT 0000882796-25-000017 4656
2025-11-13 144 xsl144X01/primary_doc.xml 0001959173-25-006976 000-23186 251476059 33 5099
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-25-000052 005-44055 251475022 34 18781
2025-11-04 10-Q 10-Q 0001628280-25-048785 000-23186 251448845 34 13477245 1 1
2025-11-03 8-K FORM 8-K 2.02,7.01,9.01 0001171843-25-006881 000-23186 251442099 34 386492 1 1
2025-10-14 425 425 0001140361-25-038091 62066
2025-10-14 425 425 0001140361-25-038088 497631
2025-10-14 425 425 0001140361-25-038086 17655
2025-10-14 425 425 0001140361-25-038032 4407104
2025-10-14 8-K 8-K 1.01,2.02,5.02,8.01,9.01 0001140361-25-038031 000-23186 251389592 34 4711459 1 1
2025-10-01 8-K 8-K 1.01,8.01,9.01 0001140361-25-036875 000-23186 251362619 34 1496563 1 1
2025-09-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-001316 005-44055 251325738 34 16622
2025-09-03 4 PRIMARY DOCUMENT 0000882796-25-000013 4476
2025-09-03 4 PRIMARY DOCUMENT 0000882796-25-000005 4472
2025-09-03 4 PRIMARY DOCUMENT 0000882796-25-000003 4491
2025-08-15 4 PRIMARY DOCUMENT 0001127602-25-020491 11757
2025-08-13 144 xsl144X01/primary_doc.xml 0001959173-25-005151 000-23186 251210003 33 4883
2025-08-12 S-8 FORM S-8 0001171843-25-005329 333-289527 251206734 33 208907 1 1
2025-08-11 8-K FORM 8-K 5.02 0001171843-25-005265 000-23186 251200141 34 187415 1 1
2025-08-05 10-Q 10-Q 0001628280-25-037795 000-23186 251184798 34 9157591 1 1
2025-08-04 8-K FORM 8-K 2.02,7.01,9.01 0001171843-25-004977 000-23186 251177978 34 357042 1 1
2025-07-31 8-K FORM 8-K 5.02,7.01,9.01 0001171843-25-004869 000-23186 251169354 34 235630 1 1
2025-07-28 4 PRIMARY DOCUMENT 0001127602-25-019632 7162
2025-07-11 3 xslF345X02/ownership.xml 0001171843-25-004435 11966
2025-07-07 8-K FORM 8-K 5.02,7.01,9.01 0001171843-25-004324 000-23186 251106965 34 230617 1 1
2025-06-30 8-K 8-K 1.01,9.01 0001140361-25-024089 000-23186 251088764 34 2533420 1 1
2025-06-27 8-K FORM 8-K 8.01,9.01 0001171843-25-004186 000-23186 251082182 34 240643 1 1
2025-06-25 8-K FORM 8-K 8.01 0001171843-25-004091 000-23186 251070852 34 188472 1 1
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003918 15167
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003917 15243
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003916 15133
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003915 15121
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003914 15126
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003913 15154
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003912 16168
2025-06-16 4 xslF345X05/ownership.xml 0001171843-25-003911 7257
2025-06-16 8-K FORM 8-K 5.02,5.07,9.01 0001171843-25-003910 000-23186 251050225 34 366984 1 1
2025-06-04 8-K FORM 8-K 5.02 0001171843-25-003662 000-23186 251021899 34 185557 1 1
2025-06-03 4 PRIMARY DOCUMENT 0001127602-25-016424 4492
2025-06-03 4 PRIMARY DOCUMENT 0001127602-25-016419 4479
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002355 005-44055 25949339 34 10546
2025-05-14 8-K FORM 8-K 8.01,9.01 0001171843-25-003152 000-23186 25942633 34 233639 1 1
2025-05-06 4 PRIMARY DOCUMENT 0001127602-25-013478 7086
2025-05-06 3 xslF345X02/ownership.xml 0001171843-25-002822 10235
2025-05-06 10-Q 10-Q 0001628280-25-022658 000-23186 25917125 34 8013686 1 1
2025-05-05 8-K FORM 8-K 2.02,7.01,9.01 0001171843-25-002739 000-23186 25910861 34 287021 1 1
2025-05-01 8-K FORM 8-K 5.02,9.01 0001171843-25-002669 000-23186 25899383 34 226413 1 1
2025-04-24 ARS ARS 0001140361-25-015469 000-23186 25867871 34 1726657
2025-04-24 DEFA14A DEFA14A 0001140361-25-015459 000-23186 25867719 34 366185
2025-04-24 DEF 14A DEF 14A 0001628280-25-019659 000-23186 25867194 34 3513020 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000567 005-44055 25844503 34 11093
2025-04-10 8-K FORM 8-K 5.02 0001171843-25-002147 000-23186 25828294 34 196293 1 1
2025-04-02 4 PRIMARY DOCUMENT 0001127602-25-011136 4699
2025-03-11 8-K FORM 8-K 8.01 0001171843-25-001383 000-23186 25725771 34 198615 1 1
2025-03-04 4 PRIMARY DOCUMENT 0001127602-25-007884 4497
2025-03-04 8-K FORM 8-K 5.02 0001171843-25-001231 000-23186 25701605 34 194476 1 1
2025-02-25 10-K 10-K 0001628280-25-007715 000-23186 25662920 34 11479410 1 1
2025-02-24 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001171843-25-001020 000-23186 25654167 34 347268 1 1
2025-01-13 8-K FORM 8-K 7.01 0001171843-25-000190 000-23186 25524780 34 194667 1 1
2025-01-10 8-K FORM 8-K 2.02,7.01,9.01 0001171843-25-000155 000-23186 25520389 34 232964 1 1
2025-01-08 8-K FORM 8-K 7.01 0001171843-25-000112 000-23186 25516581 34 193850 1 1
2024-12-23 4 PRIMARY DOCUMENT 0001127602-24-029971 8662
2024-12-23 4 PRIMARY DOCUMENT 0001127602-24-029969 8702
2024-12-23 4 PRIMARY DOCUMENT 0001127602-24-029965 8657
2024-12-23 4 PRIMARY DOCUMENT 0001127602-24-029952 8613
2024-12-23 4 PRIMARY DOCUMENT 0001127602-24-029948 13628
2024-12-17 4 PRIMARY DOCUMENT 0001127602-24-029602 4667
2024-12-17 4 PRIMARY DOCUMENT 0001127602-24-029592 6172
2024-12-17 4 PRIMARY DOCUMENT 0001127602-24-029582 4618
2024-12-17 4 PRIMARY DOCUMENT 0001127602-24-029573 4662
2024-12-17 4 PRIMARY DOCUMENT 0001127602-24-029566 4707
2024-12-16 4 PRIMARY DOCUMENT 0001127602-24-029494 5221
2024-12-13 144 xsl144X01/primary_doc.xml 0001971857-24-000841 000-23186 241548701 33 4669
2024-12-02 4 PRIMARY DOCUMENT 0001127602-24-028290 4498
2024-11-07 SC 13G/A UnitedStates_13G__BioCrystPh.txt 0000932471-24-000792 005-44055 241433864 34 6599
2024-11-07 SC 13G/A UnitedStates_13G__BioCrystPh.txt 0000932471-24-000791 005-44055 241433749 34 6600
2024-11-05 10-Q 10-Q 0001628280-24-045364 000-23186 241428562 34 8408708 1 1
2024-11-04 SC 13G/A UnitedStates_13G__BioCrystPh.txt 0000932471-24-000298 005-44055 241421441 34 5640
2024-11-04 8-K FORM 8-K 2.02,7.01,9.01 0001171843-24-005975 000-23186 241420733 34 321101 1 1
2024-10-17 SC 13G/A BioCryst_Pharma_Inc.htm 0000093751-24-000812 005-44055 241376608 34 56032
2024-10-02 8-K FORM 8-K 7.01,9.01 0001171843-24-005439 000-23186 241345265 34 223382 1 1
2024-09-30 8-K FORM 8-K 7.01,8.01,9.01 0001171843-24-005393 000-23186 241336655 34 227094 1 1
2024-09-10 SC 13G/A us09058v1035_091024.txt 0001086364-24-008614 005-44055 241289293 34 14143
2024-09-03 4 PRIMARY DOCUMENT 0001127602-24-023304 4498
2024-08-06 S-8 FORM S-8 0001171843-24-004489 333-281294 241179988 33 204468 1 1
2024-08-06 10-Q 10-Q 0001628280-24-035170 000-23186 241179067 34 8208950 1 1
2024-08-05 8-K FORM 8-K 2.02,7.01,9.01 0001171843-24-004422 000-23186 241173075 34 328629 1 1
2024-06-25 4 PRIMARY DOCUMENT 0001127602-24-019215 4991
2024-06-24 144 xsl144X01/primary_doc.xml 0001971857-24-000445 000-23186 241064400 33 4429
2024-06-17 4 PRIMARY DOCUMENT 0001127602-24-018846 5011
2024-06-17 144 xsl144X01/primary_doc.xml 0001971857-24-000419 000-23186 241048371 33 4461
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018737 6947
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018733 6942
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018728 6927
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018725 6939
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018720 6914
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018715 9075
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018711 8206
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018708 7601
2024-06-14 4 PRIMARY DOCUMENT 0001127602-24-018705 6971
2024-06-14 144 xsl144X01/primary_doc.xml 0001971857-24-000403 000-23186 241044797 33 4443
2024-06-13 8-K FORM 8-K 5.02,5.07,9.01 0001171843-24-003430 000-23186 241041563 34 372755 1 1
2024-06-03 4 PRIMARY DOCUMENT 0001127602-24-017302 4498
2024-06-03 4 PRIMARY DOCUMENT 0001127602-24-017295 4498
2024-05-31 4 PRIMARY DOCUMENT 0001127602-24-017121 4287
2024-05-29 4 PRIMARY DOCUMENT 0001127602-24-016776 4948
2024-05-22 4 PRIMARY DOCUMENT 0001127602-24-016190 4707
2024-05-22 4 PRIMARY DOCUMENT 0001127602-24-016188 4740
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015373 4344
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015371 4839
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015369 4769
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015367 4749
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015365 6303
2024-05-15 4 PRIMARY DOCUMENT 0001127602-24-015363 4349
2024-05-07 10-Q 10-Q 0001628280-24-021069 000-23186 24921671 34 7414985 1 1
2024-05-06 8-K FORM 8-K 2.02,7.01,9.01 0001171843-24-002550 000-23186 24915508 34 282331 1 1
2024-04-25 ARS ARS 0001140361-24-022074 000-23186 24876779 34 1772530
2024-04-25 DEFA14A DEFA14A 0001140361-24-022065 000-23186 24876731 34 444589
2024-04-25 DEF 14A DEF 14A 0001628280-24-018175 000-23186 24876528 34 3346831 1 1
2024-04-02 4 PRIMARY DOCUMENT 0001127602-24-011832 4706
2024-03-04 4 PRIMARY DOCUMENT 0001127602-24-008156 4497
2024-03-04 4 PRIMARY DOCUMENT 0001127602-24-008140 4497
2024-02-27 S-3ASR S-3ASR 0001140361-24-009789 333-277417 24688219 33 1238536
2024-02-27 10-K 10-K 0001628280-24-007205 000-23186 24686601 34 11449132 1 1
2024-02-26 8-K FORM 8-K 2.02,7.01,9.01 0001171843-24-000967 000-23186 24673522 34 315644 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023745 005-44055 24638760 34 88718
2024-02-14 SC 13G BIOCRYST PHARMACEUTICALS INC. 0000902664-24-001592 005-44055 24632866 34 62842
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020432 005-44055 24627590 34 13111
2024-01-24 SC 13G/A us09058v1035_012424.txt 0001086364-24-002734 005-44055 24557831 34 13728
2024-01-24 SC 13G/A BioCryst_Ph_Inc.txt 0000093751-24-000174 005-44055 24555473 34 8547
2024-01-18 8-K FORM 8-K 5.03,9.01 0001171843-24-000297 000-23186 24542818 34 384441 1 1
2024-01-08 8-K FORM 8-K 2.02,7.01,9.01 0001171843-24-000112 000-23186 24518282 34 231184 1 1
2024-01-04 4 PRIMARY DOCUMENT 0001127602-24-000832 7891
2023-12-20 4 PRIMARY DOCUMENT 0001127602-23-030189 4707
2023-12-20 4 PRIMARY DOCUMENT 0001127602-23-030187 6172
2023-12-20 4 PRIMARY DOCUMENT 0001127602-23-030185 4667
2023-12-20 4 PRIMARY DOCUMENT 0001127602-23-030181 4662
2023-12-20 4 PRIMARY DOCUMENT 0001127602-23-030177 4618
2023-12-18 4 PRIMARY DOCUMENT 0001127602-23-029839 8701
2023-12-18 4 PRIMARY DOCUMENT 0001127602-23-029835 10168
2023-12-18 4 PRIMARY DOCUMENT 0001127602-23-029833 8661
2023-12-18 4 PRIMARY DOCUMENT 0001127602-23-029831 8656
2023-12-18 4 PRIMARY DOCUMENT 0001127602-23-029829 8612
2023-12-01 4 PRIMARY DOCUMENT 0001127602-23-028609 4416
2023-12-01 4 PRIMARY DOCUMENT 0001127602-23-028607 4416
2023-12-01 8-K FORM 8-K 5.02 0001171843-23-007377 000-23186 231457550 34 191261 1 1
2023-11-30 8-K FORM 8-K 7.01 0001171843-23-007357 000-23186 231454085 34 193211 1 1
2023-11-08 S-8 FORM S-8 0001171843-23-006869 333-275401 231388338 33 143665
2023-11-08 10-Q 10-Q 0001628280-23-037847 000-23186 231387970 34 7850107 1 1
2023-11-03 8-K FORM 8-K 7.01,9.01 0001171843-23-006717 000-23186 231375201 34 237580 1 1
2023-11-03 8-K FORM 8-K 7.01,9.01 0001171843-23-006716 000-23186 231375192 34 231205 1 1
2023-11-02 8-K FORM 8-K 2.02,7.01,9.01 0001171843-23-006627 000-23186 231370018 34 303664 1 1
2023-10-26 8-K FORM 8-K 7.01,9.01 0001171843-23-006441 000-23186 231347742 34 224593 1 1
2023-09-05 4 PRIMARY DOCUMENT 0001127602-23-023695 4416
2023-09-05 4 PRIMARY DOCUMENT 0001127602-23-023693 4416
2023-08-07 10-Q 10-Q 0001628280-23-027820 000-23186 231148274 34 8618316 1 1
2023-08-03 8-K FORM 8-K 2.02,7.01,9.01 0001171843-23-004942 000-23186 231138007 34 304294 1 1
2023-07-11 8-K FORM 8-K 5.02 0001171843-23-004444 000-23186 231081191 34 195103 1 1
2023-06-30 S-8 S-8 0001171843-23-004273 333-273042 231059440 33 192817
2023-06-15 4 xslF345X04/ownership.xml 0001171843-23-003946 6187
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018793 6846
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018791 6892
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018788 6878
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018786 6824
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018783 8276
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018779 6849
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018775 8686
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018771 6834
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018767 6849
2023-06-15 4 PRIMARY DOCUMENT 0001127602-23-018765 6878
2023-06-15 144 xsl144X01/primary_doc.xml 0001971857-23-000276 000-23186 231016228 33 4191
2023-06-14 144 xsl144X01/primary_doc.xml 0001971857-23-000265 000-23186 231013422 33 4150
2023-06-14 8-K FORM 8-K 5.02,5.07,9.01 0001171843-23-003914 000-23186 231012985 34 385237 1 1
2023-06-02 4 PRIMARY DOCUMENT 0001127602-23-017562 4415
2023-06-02 4 PRIMARY DOCUMENT 0001127602-23-017556 4402
2023-06-02 4 PRIMARY DOCUMENT 0001127602-23-017552 4415
2023-05-08 10-Q 10-Q 0001628280-23-016458 000-23186 23898334 34 6757940 1 1
2023-05-03 8-K FORM 8-K 2.02,7.01,9.01 0001171843-23-002790 000-23186 23881641 34 263715 1 1
2023-04-27 ARS FORM ARS 0001140361-23-020956 000-23186 23857272 34 1268964
2023-04-27 DEFA14A DEFA14A 0001140361-23-020953 000-23186 23857245 34 4933165
2023-04-27 DEF 14A DEF 14A 0001140361-23-020945 000-23186 23857190 34 8102125 1 1
2023-04-18 8-K FORM 8-K 1.01,2.03,7.01,9.01 0001171843-23-002355 000-23186 23825462 34 235456 1 1
2023-04-05 4 PRIMARY DOCUMENT 0001127602-23-012587 5241
2023-03-23 4 PRIMARY DOCUMENT 0001127602-23-011193 8312
2023-03-13 8-K FORM 8-K 7.01 0001171843-23-001614 000-23186 23725646 34 195088 1 1
2023-03-02 4 PRIMARY DOCUMENT 0001127602-23-008400 4379
2023-03-02 4 PRIMARY DOCUMENT 0001127602-23-008391 4473
2023-03-02 4 PRIMARY DOCUMENT 0001127602-23-008383 4379
2023-03-02 4 PRIMARY DOCUMENT 0001127602-23-008381 4366
2023-02-27 10-K 10-K 0001628280-23-005259 000-23186 23675662 34 10901344 1 1
2023-02-21 8-K FORM 8-K 2.02,7.01,9.01 0001171843-23-001058 000-23186 23645232 34 334901 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021487 005-44055 23628456 34 104846
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015458 005-44055 23602605 34 13030
2023-02-06 SC 13G/A BioCryst_Pharmaceuticals_Inc.txt 0000093751-23-000212 005-44055 23588865 34 8508
2023-02-03 SC 13G/A us09058v1035_020323.txt 0001306550-23-007838 005-44055 23586405 34 13466
2023-02-02 4 PRIMARY DOCUMENT 0001127602-23-003172 14075
2023-02-02 4 PRIMARY DOCUMENT 0001127602-23-003163 6793
2023-01-09 8-K FORM 8-K 2.02,7.01,9.01 0001171843-23-000154 000-23186 23516536 34 242355 1 1
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028084 6763
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028082 6852
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028080 8315
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028078 6809
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028076 6812
2022-12-21 4 PRIMARY DOCUMENT 0001127602-22-028074 6807
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027894 6675
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027887 5213
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027883 5168
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027875 5173
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027870 5175
2022-12-19 4 PRIMARY DOCUMENT 0001127602-22-027858 5124
2022-12-15 8-K FORM 8-K 7.01,8.01,9.01 0001171843-22-008057 000-23186 221463632 34 229043 1 1
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026834 8221
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026832 15739
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026830 4381
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026828 4381
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026825 4367
2022-12-02 4 PRIMARY DOCUMENT 0001127602-22-026823 4474
2022-11-16 4 PRIMARY DOCUMENT 0001127602-22-025761 12071
2022-11-04 10-Q 10-Q 0001628280-22-028463 000-23186 221362587 34 7547783 1 1
2022-11-01 8-K FORM 8-K 2.02,7.01,9.01 0001171843-22-006936 000-23186 221348469 34 308458 1 1
2022-09-14 8-K FORM 8-K 5.02,7.01,9.01 0001171843-22-006097 000-23186 221243098 34 220718 1 1
2022-09-02 4 PRIMARY DOCUMENT 0001127602-22-022018 4381
2022-09-02 4 PRIMARY DOCUMENT 0001127602-22-022014 4367
2022-09-02 4 PRIMARY DOCUMENT 0001127602-22-022009 4474
2022-09-02 4 PRIMARY DOCUMENT 0001127602-22-022003 4381
2022-08-31 S-8 FORM S-8 0001171843-22-005878 333-267193 221218332 33 153237
2022-08-25 8-K FORM 8-K 7.01,8.01,9.01 0001171843-22-005818 000-23186 221192952 34 6314344 1 1
2022-08-05 10-Q 10-Q 0001628280-22-021373 000-23186 221141179 34 7665566 1 1
2022-08-04 8-K FORM 8-K 2.02,7.01,9.01 0001171843-22-005341 000-23186 221134610 34 294481 1 1
2022-07-14 S-8 S-8 0001171843-22-004859 333-266132 221083373 33 103013
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017169 6823
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017167 6818
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017165 6921
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017163 6784
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017160 6803
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017157 6818
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017153 6847
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017148 6815
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017144 6861
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017141 6847
2022-06-09 4 PRIMARY DOCUMENT 0001127602-22-017138 6793
2022-06-07 8-K FORM 8-K 5.02,5.07,9.01 0001171843-22-004206 000-23186 221001749 34 374879 1 1
2022-06-02 4 PRIMARY DOCUMENT 0001127602-22-016409 4452
2022-06-02 4 PRIMARY DOCUMENT 0001127602-22-016402 4467
2022-06-02 4 PRIMARY DOCUMENT 0001127602-22-016395 4463
2022-06-02 4 PRIMARY DOCUMENT 0001127602-22-016390 4570
2022-05-26 DEFA14A DEFA14A 0001140361-22-020820 000-23186 22971072 34 76723
2022-05-09 10-Q FORM 10-Q 0001171843-22-003423 000-23186 22903196 34 6582077 1 1
2022-05-05 8-K FORM 8-K 2.02,7.01,9.01 0001171843-22-003265 000-23186 22893989 34 271915 1 1
2022-04-25 DEFA14A DEFA14A 0001140361-22-015747 000-23186 22850081 34 6085480
2022-04-25 DEF 14A DEF14A 0001140361-22-015743 000-23186 22850051 34 3154101
2022-04-20 4 PRIMARY DOCUMENT 0001127602-22-012272 8126
2022-04-11 8-K FORM 8-K 7.01 0001171843-22-002497 000-23186 22818507 34 198710 1 1
2022-04-08 8-K FORM 8-K 8.01,9.01 0001171843-22-002466 000-23186 22815566 34 219071 1 1
2022-04-04 4 PRIMARY DOCUMENT 0001127602-22-011188 5117
2022-03-14 4 PRIMARY DOCUMENT 0001127602-22-009124 10070
2022-03-09 4 PRIMARY DOCUMENT 0001127602-22-008780 4664
2022-03-03 4 PRIMARY DOCUMENT 0001127602-22-008047 7753
2022-03-02 4 PRIMARY DOCUMENT 0001127602-22-007730 4365
2022-03-02 4 PRIMARY DOCUMENT 0001127602-22-007725 4473
2022-03-02 4 PRIMARY DOCUMENT 0001127602-22-007722 4369
2022-03-02 4 PRIMARY DOCUMENT 0001127602-22-007717 4355
2022-02-28 10-K FORM 10-K 0001171843-22-001460 000-23186 22690938 34 12506576 1 1
2022-02-23 8-K FORM 8-K 2.02,7.01,9.01 0001171843-22-001277 000-23186 22660582 34 319416 1 1
2022-02-22 8-K FORM 8-K 7.01,9.01 0001171843-22-001239 000-23186 22654924 34 224250 1 1
2022-02-17 8-K FORM 8-K 7.01 0001171843-22-001136 000-23186 22648058 34 193814 1 1
2022-02-16 4 PRIMARY DOCUMENT 0001127602-22-005295 8566
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022834 005-44055 22632142 34 91780
2022-02-10 4 xslF345X03/ownership.xml 0001171843-22-000942 5443
2022-02-10 3 xslF345X02/ownership.xml 0001171843-22-000941 11158
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016640 005-44055 22606656 34 13023
2022-02-09 SC 13G/A BIOCRYST_PHARMACEUTICALS_INC.txt 0000093751-22-000019 005-44055 22605153 34 8465
2022-02-08 8-K FORM 8-K 5.02,9.01 0001171843-22-000840 000-23186 22599286 34 223842 1 1
2022-02-01 SC 13G/A us09058v1035_020122.txt 0000834237-22-004595 005-44055 22580028 34 13466
2022-01-18 UPLOAD filename1.pdf 0000000000-22-000611 39676
2022-01-14 CORRESP filename1.htm 0001171843-22-000275 36942
2022-01-13 4 PRIMARY DOCUMENT 0001127602-22-001458 10111
2022-01-13 4/A PRIMARY DOCUMENT 0001127602-22-001456 4690
2022-01-13 4/A PRIMARY DOCUMENT 0001127602-22-001454 4695
2022-01-13 4/A PRIMARY DOCUMENT 0001127602-22-001452 4646
2022-01-10 8-K FORM 8-K 2.02,7.01,9.01 0001171843-22-000172 000-23186 22519647 34 237078 1 1
2022-01-07 8-K FORM 8-K 7.01,9.01 0001171843-22-000150 000-23186 22516715 34 224384 1 1
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031141 6816
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031137 6832
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031134 6802
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031130 6856
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031126 6767
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031121 6812
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031118 6801
2021-12-16 4 PRIMARY DOCUMENT 0001127602-21-031116 13460
2021-12-14 UPLOAD filename1.pdf 0000000000-21-014940 43166
2021-12-09 4 PRIMARY DOCUMENT 0001127602-21-030610 8208
2021-12-02 4 PRIMARY DOCUMENT 0001127602-21-030063 4356
2021-12-02 4 PRIMARY DOCUMENT 0001127602-21-030059 4366
2021-12-02 4 PRIMARY DOCUMENT 0001127602-21-030052 4370
2021-12-02 4 PRIMARY DOCUMENT 0001127602-21-030043 4474
2021-11-29 8-K FORM 8-K 7.01,9.01 0001171843-21-008198 000-23186 211452990 34 224035 1 1
2021-11-24 4 xslF345X03/ownership.xml 0001171843-21-008177 4435
2021-11-24 4 xslF345X03/ownership.xml 0001171843-21-008176 4447
2021-11-22 8-K FORM 8-K 1.01,2.03,3.02 0001171843-21-008117 000-23186 211430137 34 223443 1 1
2021-11-17 4 PRIMARY DOCUMENT 0001127602-21-029440 8568
2021-11-04 10-Q FORM 10-Q 0001171843-21-007570 000-23186 211380546 34 6792927 1 1
2021-11-03 8-K FORM 8-K 2.02,7.01,9.01 0001171843-21-007423 000-23186 211373672 34 304132 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 257.30M 2026-10-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
dei EntityPublicFloat Entity Public Float USD 1.86B 2025-06-30 2025 FY 10-K 2026-02-26 0001628280-26-012240
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 596.12M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.09M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 5.69M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 200.89 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.16M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd PeoTotalCompAmt PeoTotalCompAmt USD 12.95M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 104.7 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026822
ffd NetFeeAmt NetFeeAmt USD 8,787.3 2026-08-04 S-8 2026-08-05 0001171843-26-005245
ffd TtlFeeAmt TtlFeeAmt USD 8,787.3 2026-08-04 S-8 2026-08-05 0001171843-26-005245
ffd TtlOfferingAmt TtlOfferingAmt USD 63.63M 2026-08-04 S-8 2026-08-05 0001171843-26-005245
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-8 2026-08-05 0001171843-26-005245
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 14.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 121.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 110.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 11.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 9.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -607,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.71B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 546.70M 2015-03-31 2015 Q1 10-Q 2015-05-08 0001171843-15-002688
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 4,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.24M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 14.82M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap AdvertisingExpense Advertising Expense USD 13.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 44.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 1.61M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192102
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 898,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001628280-23-016458
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 32,000 2015-12-31 2015 FY 10-K 2016-02-26 0001171843-16-008207
us-gaap Assets Assets USD 591.07M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AssetsCurrent Assets, Current USD 531.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 333.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 329,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 215.13M 2022-09-30 2022 Q3 10-Q 2022-11-04 0001628280-22-028463
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 105.41M 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 244,000 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 105.24M 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 278.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 278.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 216.14M 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 3.00M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 13.46M 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210965
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 15,000 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210965
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 36,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001171843-15-002688
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 27,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001171843-15-002688
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 12,000 2011-12-31 2012 FY 10-K 2013-03-11 0001193125-13-100999
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 608,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001628280-26-031238
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 47,000 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 96.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 55.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 28.18M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 98.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 106.88M 2025-03-31 2025 Q1 10-Q 2025-05-06 0001628280-25-022658
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations USD 7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2019-11-21 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 11.77M 2019-11-21 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 69.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 450.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 256.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 256.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CommonStockValue Common Stock, Value, Issued USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -606.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.54M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 11.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 10.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 1.14M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap CostsAndExpenses Costs and Expenses USD 1.10B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 238,000 2018-12-31 2019 FY 10-K 2020-03-13 0001171843-20-001710
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 1.12M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 4.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 3.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 11.93M 2023-03-31 2023 Q1 10-Q 2023-05-08 0001628280-23-016458
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 695,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss USD 277.65M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 243.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 30 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 9,000 2019-03-31 2019 Q1 10-Q 2019-05-09 0001171843-19-003220
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 79,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 34,000 2022-03-31 2022 Q1 10-Q 2022-05-09 0001171843-22-003423
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -1.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 54,000 2018-12-31 2019 FY 10-K 2020-03-13 0001171843-20-001710
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 8.18M 2016-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -184,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.85M 2017-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 384.35M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 40.88M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.61M 2013-12-31 2014 FY 10-K 2015-03-02 0001171843-15-001186
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 252,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 119.94M 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 82.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 26.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.05M 2015-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 85.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 40.07M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 1.61M 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD -2.29M 2014-12-31 2014 FY 10-K 2015-03-02 0001171843-15-001186
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 380.52M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 11,000 2022-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains Deferred Tax Liabilities, Unrealized Currency Transaction Gains USD 231,000 2018-12-31 2019 FY 10-K 2020-03-13 0001171843-20-001710
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 5.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap Depreciation Depreciation USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.90M 2016-09-30 2016 Q3 10-Q 2016-11-08 0001171843-16-013033
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 972,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1,030 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.2 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 71,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -101,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 50.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 111.80M 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037847
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2014-09-30 2014 Q3 10-Q 2014-11-07 0001171843-14-005367
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 15.65M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 12.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 623,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 991,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 26,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 458,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 325,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 154,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 2.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 3.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.101 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ForeignCurrencyDerivativeLiabilitiesAtFairValue Foreign Currency Derivative Liabilities at Fair Value (Deprecated 2014-01-31) USD 981,000 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192102
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -7,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001171843-21-001411
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -7,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments USD -176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap GainLossOnForeignCurrencyFairValueHedgeDerivatives Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives USD 1.53M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460637
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 3.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -93,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.33M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001171843-15-006102
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 9.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 172.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -602.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 94.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -182.81M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001171843-21-001411
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2.22M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001628280-25-048785
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 73.47M 2017-12-01 2017-12-31 2019 FY 10-K 2020-03-13 0001171843-20-001710
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -52.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 2.35M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 56.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 3.72M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 4.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 4.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -217,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD -1.21M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -45.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 3.40M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001171843-15-002688
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 7.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -7.10M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001171843-18-007788
us-gaap IncreaseDecreaseInDerivativeAssets Increase (Decrease) in Derivative Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 16.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 12.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 1.74M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 4.67M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-11 0001193125-13-100999
us-gaap InterestAndOtherIncome Interest and Other Income USD 7.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InterestExpense Interest Expense USD 49.24M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0001628280-24-035170
us-gaap InterestExpenseDebt Interest Expense, Debt USD 56.31M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0001628280-23-027820
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 62.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 22.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InterestPayableCurrent Interest Payable, Current USD 21.67M 2020-12-31 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap InventoryAdjustments Inventory Adjustments USD 170,000 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037847
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 5.49M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 416,000 2014-12-31 2015 FY 10-K 2016-02-26 0001171843-16-008207
us-gaap InventoryGross Inventory, Gross USD 46.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryNet Inventory, Net USD 13.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 31.27M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 10.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 263,000 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 206,000 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 29.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 6.04M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap InventoryWriteDown Inventory Write-down USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap Investments Investments USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001171843-21-007570
us-gaap InvestmentsAndCash Investments and Cash USD 68.70M 2016-09-30 2016 Q3 10-Q 2016-11-08 0001171843-16-013033
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 11.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.43M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.59M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.54M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 791,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap Liabilities Liabilities USD 988.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 591.07M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LiabilitiesCurrent Liabilities, Current USD 195.83M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 10.00M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460637
us-gaap LineOfCredit Long-term Line of Credit USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001171843-21-001411
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001171843-21-001411
us-gaap LongTermDebt Long-term Debt USD 298.14M 2021-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 20.00M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 1.00M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001171843-18-007788
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 20.00M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001171843-19-007384
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 20.00M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001171843-20-003557
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 20.00M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 5.00M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001171843-20-007740
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 395.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LongTermInvestments Long-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 30.00M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001171843-15-006102
us-gaap LossOnContractTermination Loss on Contract Termination USD 440,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap LossOnSaleOfInvestments Loss on Sale of Investments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 389.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 48.82M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001171843-17-004830
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -457.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -13.03M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001171843-17-004830
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 75.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -18.19M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001171843-17-004830
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -605.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 251.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -52.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NontradeReceivablesCurrent Nontrade Receivables, Current USD 2.37M 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-434942
us-gaap NotesPayableCurrent Notes Payable, Current USD 30.00M 2020-12-31 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap NotionalAmountOfNetInvestmentHedgingInstruments Notional Amount of Net Investment Hedging Instruments (Deprecated 2013-01-31) USD 5.95M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460637
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -549.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 5.25M 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.30M 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 503,000 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 491,000 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 524,000 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 934,000 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.50M 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 758,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.42M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 20.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -73,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -572,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -566,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0001628280-24-021069
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 786,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0001628280-24-045364
us-gaap OtherIncome Other Income USD 12.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap OtherInventorySupplies Other Inventory, Supplies, Gross USD 263,000 2013-12-31 2014 FY 10-K 2015-03-02 0001171843-15-001186
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 3.54M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001171843-19-007384
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 7.14M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001628280-23-016458
us-gaap PaymentsForHedgeFinancingActivities Payments for Hedge, Financing Activities USD 2.19M 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001171843-17-006746
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 61,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap PaymentsForRestructuring Payments for Restructuring USD 64,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 4.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 34,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD -17.81M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460637
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 3.67M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218117
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 275.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 489.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 845,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 343,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001171843-20-001710
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 20.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 6.92M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001171843-21-007570
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD -6.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 400.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 29.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 108.10M 2020-06-01 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 73.07M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 308.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromSaleOfFurnitureAndFixtures Proceeds from Sale of Furniture and Fixtures USD 12,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap ProceedsFromSaleOfOtherAssetsInvestingActivities Proceeds from Sale of Other Assets, Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 8.52M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037847
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 300,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001171843-16-013033
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18.18M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 1.00M 2024-09-30 2024 Q3 10-Q 2024-11-05 0001628280-24-045364
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 3.45M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001171843-18-005928
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 170.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 518,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.79M 2026-03-31 2026 Q1 10-Q 2026-05-06 0001628280-26-031238
us-gaap RestructuringCharges Restructuring Charges USD -97,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-02 0001171843-15-001186
us-gaap RestructuringCosts Restructuring Costs USD 6.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap RestructuringReserve Restructuring Reserve USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 890,000 2010-10-01 2010-12-31 2012 FY 10-K 2013-03-11 0001193125-13-100999
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD 97,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD 1.30M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210965
us-gaap RetailLandSaleReceivablesWeightedAverageInterestRate Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31) pure 0.02 2011-06-01 2011-06-30 2014 Q2 10-Q 2014-08-08 0001171843-14-003839
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.11B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 554.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap Revenues Revenues USD 25.19M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap RoyaltyExpense Royalty Expense USD 126,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001171843-21-001411
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 10.54M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5.23 2012-03-15 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 1.50M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 25.19M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 225.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 44.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 582,084 2021-08-01 2021-08-09 2021 Q3 10-Q 2021-11-04 0001171843-21-007570
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 44.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 22,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 34,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-08 0001171843-14-003839
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.82 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.014 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 3.80M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.27M 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 22.89M 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 832,000 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.55 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 717,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 10.78 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.53M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 2.25M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 7.60M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.03 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 17.69M 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 6.24 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 7.02 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.10M 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.99 2013-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 15.93M 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.43 2018-12-31 2018 FY 10-K 2019-03-14 0001171843-19-001727
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 9.31M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001171843-18-001855
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 5.91M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.68 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) shares 3.75M 2014-01-01 2014-12-31 2015 FY 10-K 2016-02-26 0001171843-16-008207
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 1.37 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 8.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.63 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 7.22 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.2 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-27 0001171843-17-001159
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 7.17 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 18,828 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 36,520 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 8.59 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 18 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharePrice Share Price USD/shares 1.85 2013-12-31 2015 FY 10-K 2016-02-26 0001171843-16-008207
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 4.5 2020-06-01 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 59,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap ShortTermInvestments Short-term Investments USD 278.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -397.38M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan Stock Issued During Period, Shares, Employee Stock Ownership Plan shares 193,000 2012-03-01 2012-03-15 2014 FY 10-K 2015-03-02 0001171843-15-001186
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 369,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.85M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001628280-24-007205
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 251.66M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 836,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 25.00M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460637
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 49,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001628280-25-007715
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.41M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 410,000 2022-12-31 2022 FY 10-K 2023-02-27 0001628280-23-005259
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 12,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 750,000 2021-12-31 2021 FY 10-K 2022-02-28 0001171843-22-001460
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 14.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 603,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 386,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 241,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-10 0001193125-14-091609
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -68.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012240
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 250.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 72.34M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001171843-15-002688
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 250.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070112
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 47.10M 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218117

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →